An Integrated Analysis of Cardio-Vascular Adverse Events of Carfilzomib, Cyclophosphamide and Dexamethasone in Elderly Newly Diagnosed Myeloma Patients Enrolled in 3 Phase I/II Trials / Bringhen, S; Petrucci, Mt; Giuliani, Nicola; Carella, Am; Genuardi, M; Di Toritto, Tc; Malfitano, A; Musto, P; Ria, R; Ciccone, G; Omede, P; Offidani, M; Musolino, C; Liberati, Am; De Paoli, L; Ballanti, S; Galieni, P; Cavo, M; Conticello, C; Foa, R; Corradini, P; Gaidano, G; Palumbo, A; Sonneveld, P; Boccadoro, M.. - In: BLOOD. - ISSN 0006-4971. - 128:22(2016).

An Integrated Analysis of Cardio-Vascular Adverse Events of Carfilzomib, Cyclophosphamide and Dexamethasone in Elderly Newly Diagnosed Myeloma Patients Enrolled in 3 Phase I/II Trials

GIULIANI, Nicola;
2016-01-01

2016
An Integrated Analysis of Cardio-Vascular Adverse Events of Carfilzomib, Cyclophosphamide and Dexamethasone in Elderly Newly Diagnosed Myeloma Patients Enrolled in 3 Phase I/II Trials / Bringhen, S; Petrucci, Mt; Giuliani, Nicola; Carella, Am; Genuardi, M; Di Toritto, Tc; Malfitano, A; Musto, P; Ria, R; Ciccone, G; Omede, P; Offidani, M; Musolino, C; Liberati, Am; De Paoli, L; Ballanti, S; Galieni, P; Cavo, M; Conticello, C; Foa, R; Corradini, P; Gaidano, G; Palumbo, A; Sonneveld, P; Boccadoro, M.. - In: BLOOD. - ISSN 0006-4971. - 128:22(2016).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2832919
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact